You might have noticed that new TV ads for the birth control pill Yaz
are mentioning that the FDA wants them to correct a few points they made in previous ads. The FDA criticized Bayer for overstating the drug’s ability to improve women’s moods and clear up acne, while understating the risks involved.
The FDA (and the attorneys general in 27 states) are requiring Bayer to run the new ads correcting the errors, a marketing campaign that is costing Bayer $20 million.
Yaz is currently the best selling oral hormonal contraception pill in
the United States, which makes the issue of setting the record straight all the more important. To read more about the controversy surrounding the Yaz advertising campaign, check out this New York Times article.